International Journal of Antimicrobial Agents
Volume 36, Issue 4 , Pages 332-339, October 2010

Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept

  • Jason A. Roberts

      Affiliations

    • Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia
    • Pharmacy Department, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • Department of Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • Corresponding Author InformationCorresponding author. Present address: Burns Trauma and Critical Care Research Centre, Level 3 Ned Hanlon Building, Royal Brisbane and Women's Hospital, Butterfield Street, Brisbane, Queensland 4029, Australia. Tel.: +61 7 3636 4108; fax: +61 7 3636 3542.
    • ,
  • Marta Ulldemolins

      Affiliations

    • Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia
    • Critical Care Department, Vall d’Hebron University Hospital; Institut de Recerca Vall d’Hebron-Universitat Autònoma de Barcelona (UAB)-CIBER Enfermedades Respiratorias, Barcelona, Spain
    • ,
  • Michael S. Roberts

      Affiliations

    • Therapeutics Research Unit, The University of Queensland, Brisbane, Australia
    • School of Pharmacy, University of South Australia, Adelaide, Australia
    • ,
  • Brett McWhinney

      Affiliations

    • Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • ,
  • Jacobus Ungerer

      Affiliations

    • Department of Chemical Pathology, Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • ,
  • David L. Paterson

      Affiliations

    • Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, Australia
    • University of Queensland Centre for Clinical Research, The University of Queensland, Brisbane, Australia
    • ,
  • Jeffrey Lipman

      Affiliations

    • Burns, Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia
    • Department of Intensive Care, Royal Brisbane and Women's Hospital, Brisbane, Australia

Received 16 May 2010; accepted 9 June 2010. published online 04 August 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0924-8579(10)00249-9

doi:10.1016/j.ijantimicag.2010.06.008

International Journal of Antimicrobial Agents
Volume 36, Issue 4 , Pages 332-339, October 2010

Article Tools

* Image Usage & Resolution